Compound Detail
CHEMBL2105762
OMARIGLIPTIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2
Basic Information
| ChEMBL ID | CHEMBL2105762 |
| Name | OMARIGLIPTIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MKMPWKUAHLTIBJ-ISTRZQFTSA-N |
4
Targets
15
Activities
4
Assay Types
25
PK Parameters
20
Publications
4
Known Names
2
Indications
1
Mechanisms
Molecular Properties
398.4
MW (Da)
1.14
ALogP
7
HBA
1
HBD
90.5
PSA (Ų)
0.83
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2015 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dipeptidyl peptidase IV inhibitor | INHIBITOR | Dipeptidyl peptidase 4 | ✓ | ✓ |
Indications
Diabetes Mellitus Diabetes Mellitus, Type 2
Activity Summary
IC50 11 meas. best 8.8
Kd 2 meas. best 8.56
EC50 1 meas. best 8.6
Ki 1 meas. best 9.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 CHEMBL284 | Ki | 9.1 | 9.1 | 0.8 | 1 |
| Dipeptidyl peptidase 4 CHEMBL284 | IC50 | 8.8 | 8.6538 | 1.6 | 8 |
| Dipeptidyl peptidase 4 CHEMBL284 | EC50 | 8.6 | 8.6 | 2.5 | 1 |
| Dipeptidyl peptidase 4 CHEMBL284 | Kd | 8.56 | 8.56 | 2.8 | 2 |
| Dipeptidyl peptidase 4 CHEMBL4653 | IC50 | 8.38 | 8.38 | 4.2 | 1 |
| Dipeptidyl peptidase 4 CHEMBL3883 | IC50 | 7.36 | 7.36 | 43.9 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.41 | 4.41 | 39000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1993395.32 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4095.0 | ng.hr.mL-1 | Mus musculus |
| CL | 1.1 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.9 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.9 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 1.89 | mL.min-1.g-1 | Mus musculus |
| CL | 7.39 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 371000.0 | nM | Rattus norvegicus |
| Cmax | 2002.81 | nM | Mus musculus |
| F | -100.0 | % | Rattus norvegicus |
| F | 100.0 | % | Canis lupus familiaris |
| F | 100.0 | % | Canis lupus familiaris |
| F | 95.0 | % | Mus musculus |
| Fu | 0.38 | - | Mus musculus |
| Fu | 0.15 | - | Rattus norvegicus |
| Fu | 0.43 | - | Canis lupus familiaris |
| Fu | 0.68 | - | Homo sapiens |
| T1/2 | 11.0 | hr | Rattus norvegicus |
| T1/2 | 22.0 | hr | Canis lupus familiaris |
| T1/2 | 22.0 | hr | Canis lupus familiaris |
| T1/2 | 11.0 | hr | Homo sapiens |
| T1/2 | 11.0 | hr | Rattus norvegicus |
| T1/2 | 3.05 | hr | Mus musculus |
| T1/2 | 4.65 | hr | Mus musculus |
| Tmax | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine